Announced Wed, 12 Aug · 17:27 IST
Allots 50.87 lakh shares on preferential basis for Radiant Parenterals acquisition
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+10.2%1-day move
₹33.82
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+10.2+15.7+21.5+23.3+24.2+29.5+56.1+72.5——
Up moveDown movePending
AI summary
Board allotted 50,87,750 equity shares at Rs 10 each (Rs 5 premium over face value of Rs 5). Of these, 46,27,750 shares worth Rs 4.63 crore issued to existing shareholders of Radiant Parenterals via share swap, giving the company 100% of Radiant, which will become a wholly owned subsidiary. Balance 4,60,000 shares (Rs 46 lakh) allotted to non-promoters for cash. Radiant makes injectables and syrups; FY25 revenue was Rs 31.67 crore.
Likely market impact
Acquisition expands pharma presence via wholly owned subsidiary. Funded through share swap, so no major cash outflow, but existing holders face equity dilution.